How the FDA Built an AI Platform That 85% of Its Staff Now Use Daily
Summary
The FDA broke down center silos to launch an enterprise AI platform that reached 85% staff adoption in just two months, cutting regulatory research times from days to three minutes. Powered by a governed data
Summary generated by brickster.ai. For the full article, follow the source link above.
More from Databricks Blog
Get Started with Genie One: Top AI Cowork Use Cases for Business Users
Genie One enables business users to automate recurring reviews and meeting workflows by pulling governed data into calendar-aware briefs and consistent reports. By packaging these processes into reusable AI skills and agents, teams can
The EU Digital Product Passport: a traceability deadline
The EU Digital Product Passport makes product traceability a mandatory condition for market access starting in February 2027, turning data availability and quality into the primary implementation challenge for global producers. Databricks provides
Building AI Literacy: Frameworks, Tools, and Practices
A three-domain framework encompassing Understand, Evaluate, and Use offers organizations a structured approach to AI literacy, curriculum development, and governance policies. Developing these critical competencies—including identifying model hallucinations and bias—
AI Applications in Finance: A Practical Use Case Guide
Finance teams can establish a low-risk path to enterprise scale by adopting a staged rollout featuring two prioritized pilots, a 90–120 day evaluation window, and rigorous ROI measurement. Successful deployment
Permission isn't purpose: Intent-based authorization in Omnigent
Omnigent introduces intent-based authorization for AI agents, binding each session to a declared, human-approved purpose rather than relying solely on identity-based permissions. Because any action outside this